Resilience Is Key For Medtechs Facing Provider And Payer Flux In 2018

Medtech firms entered 2018 knowing that demands from providers and payers are increasing, the pace of business is quickening, and at the same time patients are more empowered and market access routes are more exacting than ever. Against this backdrop, PwC explains the top health industry issues for the coming year, highlights the forces that will have the most impact on the industry in 2018 and explains why manufacturers need to be nimble.

What changes should medtech companies, including those with IT applications, expect from 2018, or, put another way, how should they prepare to serve a global health care sector that is expecting "more and different" from its industry partners? PwC partner and US health services sector leader Gurpreet Singh believes that industry players need to show creativity and flexibility, but most of all resilience, to stay one step ahead of the changes – and the competition.

Speaking to In Vivo after the release of “Top Health Industry Issues of 2018,” the PwC Health Research Institute's...

More from Business Strategy

More from In Vivo

Turning Defense Into Attack: Snapshots Of A Changing Medtech Market And How To Respond

 
• By 

Against a backdrop of shifting trade policies, the end of multilateral market approaches and renewed focus on supply chain resilience, medtechs are doubling down on innovation in products and processes – using AI – and keeping unmet needs and outcomes in the center of the target.

AI Agents Set To Reshape Biopharma’s Workforce And Operations

 
• By 

While biopharma companies experiment with genAI, agentic AI is rapidly shifting the work paradigm towards one of autonomous digital workers that can handle entire process flows.

MitoRx’s Muscle-Preserving Obesity Drug Takes Aim At GLP-1 Limitations

 
• By 

UK biotech targets the root cause of metabolic disease while preserving muscle mass in a crowded obesity market.